SUPN - Supernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing rule
Supernus Pharmaceuticals (NASDAQ:SUPN) notified the Nasdaq that it is not in compliance with the filing requirement due to its failure to timely file its annual report. SUPN currently anticipates filing its annual report on or before Apr. 4 and thereby regaining compliance with the filing rule.
For further details see:
Supernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing rule